APG-115 Alone or in Combination With APG-2575 in Children With Recurrent or Refractory Neuroblastoma or Solid Tumors

NCT05701306 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuroblastoma
Solid Tumor

Interventions

DRUG: APG-115
DRUG: APG-2575

Sponsor

Ascentage Pharma Group Inc.

Collaborators

[object Object]